» Articles » PMID: 21336992

Spontaneous Regression of Septum Pellucidum/forniceal Pilocytic Astrocytomas--possible Role of Cannabis Inhalation

Overview
Specialty Pediatrics
Date 2011 Feb 22
PMID 21336992
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Spontaneous regression of pilocytic astrocytoma after incomplete resection is well recognized, especially for cerebellar and optic pathway tumors, and tumors associated with Neurofibromatosis type-1 (NF1). The purpose of this report is to document spontaneous regression of pilocytic astrocytomas of the septum pellucidum and to discuss the possible role of cannabis in promoting regression.

Case Report: We report two children with septum pellucidum/forniceal pilocytic astrocytoma (PA) tumors in the absence of NF-1, who underwent craniotomy and subtotal excision, leaving behind a small residual in each case. During Magnetic Resonance Imaging (MRI) surveillance in the first three years, one case was dormant and the other showed slight increase in size, followed by clear regression of both residual tumors over the following 3-year period. Neither patient received any conventional adjuvant treatment. The tumors regressed over the same period of time that cannabis was consumed via inhalation, raising the possibility that the cannabis played a role in the tumor regression.

Conclusion: We advise caution against instituting adjuvant therapy or further aggressive surgery for small residual PAs, especially in eloquent locations, even if there appears to be slight progression, since regression may occur later. Further research may be appropriate to elucidate the increasingly recognized effect of cannabis/cannabinoids on gliomas.

Citing Articles

Exploring the therapeutic potential of cannabinoids in cancer by modulating signaling pathways and addressing clinical challenges.

Faiz M, Naeem F, Irfan M, Aslam M, Estevinho L, Arslan Atessahin D Discov Oncol. 2024; 15(1):490.

PMID: 39331301 PMC: 11436528. DOI: 10.1007/s12672-024-01356-8.


The Role of Cannabinoids in Advancing Cancer Treatment: Insights from Evidence-Based Medicine.

Skorzewska M, Geca K Curr Oncol Rep. 2024; 26(11):1334-1348.

PMID: 39110350 PMC: 11579082. DOI: 10.1007/s11912-024-01589-4.


Solid pilocytic astrocytoma in cavum septum pellucidum: a description of two cases and an analysis of misdiagnosis.

Liu M, Li D, Li S, Li Y, Zhang G, Jia X Quant Imaging Med Surg. 2024; 14(6):4269-4275.

PMID: 38846282 PMC: 11151232. DOI: 10.21037/qims-23-1625.


Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy.

Voicu V, Brehar F, Toader C, Covache-Busuioc R, Corlatescu A, Bordeianu A Biomolecules. 2023; 13(9).

PMID: 37759788 PMC: 10526757. DOI: 10.3390/biom13091388.


Use of Cannabis and Cannabinoids for Treatment of Cancer.

Cherkasova V, Wang B, Gerasymchuk M, Fiselier A, Kovalchuk O, Kovalchuk I Cancers (Basel). 2022; 14(20).

PMID: 36291926 PMC: 9600568. DOI: 10.3390/cancers14205142.


References
1.
COLE W . Efforts to explain spontaneous regression of cancer. J Surg Oncol. 1981; 17(3):201-9. DOI: 10.1002/jso.2930170302. View

2.
Sanchez C, Galve-Roperh I, Canova C, Brachet P, Guzman M . Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett. 1998; 436(1):6-10. DOI: 10.1016/s0014-5793(98)01085-0. View

3.
Turner W, Tsuang M . Impact of substance abuse on the course and outcome of schizophrenia. Schizophr Bull. 1990; 16(1):87-95. DOI: 10.1093/schbul/16.1.87. View

4.
Carracedo A, Gironella M, Lorente M, Garcia S, Guzman M, Velasco G . Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res. 2006; 66(13):6748-55. DOI: 10.1158/0008-5472.CAN-06-0169. View

5.
Moore T, Zammit S, Lingford-Hughes A, Barnes T, Jones P, Burke M . Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007; 370(9584):319-28. DOI: 10.1016/S0140-6736(07)61162-3. View